» Articles » PMID: 23328481

Suppression of MiRNA-708 by Polycomb Group Promotes Metastases by Calcium-induced Cell Migration

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2013 Jan 19
PMID 23328481
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

The progression of cancer to metastatic disease is a major cause of death. We identified miR-708 being transcriptionally repressed by polycomb repressor complex 2-induced H3K27 trimethylation in metastatic breast cancer. miR-708 targets the endoplasmic reticulum protein neuronatin to decrease intracellular calcium level, resulting in reduction of activation of ERK and FAK, decreased cell migration, and impaired metastases. Ectopic expression of neuronatin refractory to suppression by miR-708 rescued cell migration and metastasis defects. In patients with breast cancer, miR-708 expression was decreased in lymph node and distal metastases, suggesting a metastasis-suppressive role. Our findings uncover a mechanistic role for miR-708 in metastasis and provide a rationale for developing miR-708 as a therapeutic agent against metastatic breast cancer.

Citing Articles

Unraveling molecular signatures and prognostic biomarkers in glioblastoma: a comprehensive study on treatment resistance and personalized strategies.

Xue J, Zhang J, Zhu J Discov Oncol. 2024; 15(1):743.

PMID: 39630160 PMC: 11618281. DOI: 10.1007/s12672-024-01649-y.


Micro-RNAs in breast cancer progression and metastasis: A chromatin and metabolic perspective.

Sikder S, Bhattacharya A, Agrawal A, Sethi G, Kundu T Heliyon. 2024; 10(19):e38193.

PMID: 39386816 PMC: 11462366. DOI: 10.1016/j.heliyon.2024.e38193.


MiR-26b-5p/TET3 regulates the osteogenic differentiation of human bone mesenchymal stem cells and bone reconstruction in female rats with calvarial defects.

Ye W, Zhang C, Fan Z Mol Biol Rep. 2024; 51(1):632.

PMID: 38724827 DOI: 10.1007/s11033-024-09577-4.


Metformin: A Dual-Role Player in Cancer Treatment and Prevention.

Galal M, Al-Rimawi M, Hajeer A, Dahman H, Alouch S, Aljada A Int J Mol Sci. 2024; 25(7).

PMID: 38612893 PMC: 11012626. DOI: 10.3390/ijms25074083.


Neuronatin Promotes the Progression of Non-small Cell Lung Cancer by Activating the NF-κB Signaling.

Xiong H, Chen G, Fang K, Gu W, Qiu F Curr Cancer Drug Targets. 2024; 24(11):1128-1143.

PMID: 38299400 DOI: 10.2174/0115680096271746240103063325.